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Effect of potassium depletion on two-kidney, one-clip
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ROBERT G. BENEDETTI and STUART L. LINAS
Depart ment of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, USA
Effect of potassium depletion on two-kidney, one-clip renovascular
hypertension in the rat. There is considerable controversy about the
hemodynamic effect of potassium in hypertension. To determine if K
depletion could alter the control of blood pressure, studies were
performed in rats with 2-kidney, I-clip renovascular hypertension
(RVH) after 3 to 6 wks of severe and moderate K depletion. After
application of a 0.23 mm clip to the left renal artery, rats were placed on
a K-replete (KR) (240 mEq/kg), a moderately K-depleted (KDM) (59
mEq/kg), or a severely K-depleted (KDS) (5 mEq/kg) diet. After 3 wks,
mean arterial pressure (MAP) reached 154 3 in KR but only 121 2
in KDM (P < 0.01) and 106 4 mm Hg in KDS (P < 0.001). After 6
wks, MAP was 160 8 in KR, but only 132 Sin KDM (P <0.01) and
129 mmHginKDS(P<0.0l). PlasmaKat3wks was 4.1 .1 in KR,
but only 3.5 .1 in KDM (P < 0.05) and 2.3 .1 mEq/liter in KDS (P
<0.001). This was associated with an 8% decrease in muscle K in KDM
and a 16% decrease in muscle K in KDS. Although KDS animals did not
grow during the 6 wks of study, KDM rats gained 60% as much weight
at 3 wks, and, by 6 wks, weight gain was comparable in KDM (101 9)
and KR (110 9 g) animals (P = NS). The protective effect of K
depletion was mediated by a decrease in systemic vascular resistance
(SVR); KR .692 .06 compared to KDM .278 .01 (P < 0.001) and
KDS .287 .02 mm Hg/mi min kg' (P < 0.001). The decrease in
SVR could not be attributed to a decrease in plasma volume, plasma
catecholamines, or plasma renin activity. The pressor response to
exogenous All was reduced by 60% while the depressor response to
saralasin was reduced by 80% in KDM.
To determine if K depletion could reverse established hypertension,
rats with RVH were continued on the KR diet or changed to the K-
depleted diet. After 3 wks, systolic pressure was 161 6 in KR but only
119 4 in KDM, and 120 5 mm Hg in KDS (both P < 0.02). We
conclude that K depletion prevents the development of RVH and
reverses established RVH and that the protective effect of K depletion
may be mediated by a decrease in All vascular sensitivity.
Effet d'une déplétion potassique sur une hypertension réno-vasculaire a
deux reins, un clip, chez le rat. II existe une grande controverse quant
aux effets hemodynamiques du potassium dans l'hypertension. Afin de
determiner si Ia déplétion en K peut altérer le contrôle de Ia pression
sanguine, des etudes ont eté entreprises chez des rats avec une
hypertension rCno-vasculaire a deux reins, un clip aprCs 3 a 6 semaines
de depletion sévère ou modérée en K. AprCs pose d'un clip de 0,23 mm
sur l'artCre rCnale gauche, les rats ont été mis a un régime replete en K
(KR) (240 mEq/kg), modérément deplete (KDM) (59 mEq/kg) ou
sévCrement déplété (KDS) (5 mEq/kg). Au bout de 3 semaines, Ia
pression artCrielle moyenne (MAP) a atteint 154 3 chez les KR, et
seulement 121 2 chez les KDM (P <0,01) et 106 4mm Hg chez les
KDS (P < 0,001). Au bout de 6 semaines, MAP était de 160 8 chez
KR, et seulement 132 5 chez KDM (P <0,01) et 129 5mm Hg KDS
(P < 0,01). La kaliémie a 3 semaines Ctait de 4,1 0,1 chez KR, et
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seulement 3,5 0,1 chez KDM (P < 0,05), et 2,3 0,1 mEq/liter chez
KDS (P < 0,001). Cela était associé a une baisse de 8% du K musculaire
chez KDM eta une baisse de 16% du K musculaire chez KDS. Bien que
les animaux KDS n'aient pas grandi au cours des 6 semaines d'étude,
les KDM ont gagne 60% de poids h 3 semaines, et, au bout de 6
semaines, Ia prise de poids était comparable chez les animaux KDM
(101 9) et KR (110 9 gm) (P = NS). L'effet protecteur de Ia
déplétion en K était médié par une baisse des resistances vasculaires
systemiques (SVR); KR 0,692 0,06 par rapport a KDM 0,278 0,01(P < 0,001) eta KDS 0,287 0,2mm Hg/mi' min .kg (P <0,001).
La baisse de SVR ne pouvait pas Ctre dOe a une diminution du volume
plasmatique, des catCcholamines, ou de l'activité rénine plasmatique.
La réponse pressive a l'AII exogéne était réduite de 60% tandis que Ia
réponse depressive a Ia saralasine était réduite de 80% chez KDM.
Afin de determiner si une depletion en K pourrait rCduire une
hypertension preetablie, les rats avec RVH ont ete laissés au régime KR
ou changes pour Ic régime dCplCtC en K. Au bout de 3 semaines, Ia
pression systolique Ctait de 161 6 chez Ic KR, et seulement de 119
4 chez les KDM et de 120 5 mm Hg chez les KDS (P < 0,02 chacun).
Nous concluons qu'une depletion en K previent le developpement
d'une RVH et normalise une RVH preCtablie, et que I'effet protecteur
de Ia depletion en K pourrait être mediC par une baisse de Ia sensibilitC
vasculaire a l'AII.
Hypertension is a common clinical problem affecting more
than 30 million people in the United States. Many hypertensive
patients are treated with diuretics and develop mild
hypokalemia with a decrease in total body potassium [1]. The
effect of K on the control of blood pressure and systemic
hemodynamics in hypertension has not been systematically
evaluated. Many investigators have suggested that K depletion
is a factor that leads to hypertension [2—6], but several older
studies have demonstrated that severe K depletion lowers
blood pressure in hypertensive animals [7—9]. In these studies,
however, the protective effect of severe K depletion was not
dissociated from the profound growth retardation that occurred
during severe K depletion. Moreover, the hemodynamic mech-
anism of protection, that is, a decrease in cardiac index or
systemic vascular resistance, was not ascertained. There have,
however, been a number of studies on the hemodynamic effects
of severe K depletion in normotensive animals. With one
exception [10], these studies have demonstrated that severe K
depletion results in a decrease in systemic vascular resistance
[11—13]. The decrease in systemic vascular resistance in severe
K depletion is of particular interest because it is associated with
an increase in plasma renin activity [14] and in a decrease in the
pressor sensitivity to exogenous angiotensin II [15, 16].
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Table 1. Composition of experimental diets, mM/kg
Sodium Potassium Chloride Calcium Magnesium Phosphate
Standard rat chow 120 280 380 230 87 226
K-replete 160 240 740 105 170 190
K-depleted, severe 150 5 620 117 165 58
K-depleted, moderate 150 59 674 117 165 58
Since severe K depletion in normotensive animals appears to
have a potent vasodilatory effect even in the presence of an
increase in plasma renin activity, we questioned whether more
moderate degrees of K depletion could also prevent the in-
crease in blood pressure and systemic vascular resistance in
angiotensin-mediated hypertension. To test this hypothesis, we
developed a model of K depletion that did not cause growth
retardation and utilized this model to determine the effect of
moderate K depletion on the natural history of two-kidney, one-
clip renovascular hypertension.
Methods
Induction of hypertension and dietary manipulation
Male Sprague-Dawley rats weighing 175 to 200 g (King
Animal Labs, Madison, Wisconsin, USA) were utilized for
study. Two-kidney, one-clip (2-K, 1-C) renovascular hyperten-
sion (RVH) was produced by placing a 0.23 mm (internal
diameter) silver clip on the left renal artery. After recovering
from surgery, animals were placed on the following diets:
1. A severely K-depleted diet (ICN Pharmaceutical, Cleveland,
Ohio, USA) (KDS) containing 5 mEq K per kg/diet and
supplemented with magnesium.
2. A moderately K-depleted diet (KDM), which was prepared
by adding 54 mEq of KC1 to the severely K-depleted diet
(ICN Pharmaceutical).
3. Two different K-replete diets (KR):
a. A K-replete diet, which was prepared by adding 240 mEq
of a mixture of K salts to the severely K-depleted diet.
b. Standard rat chow (Wayne Laboratory, Wayne, Indiana,
USA) containing 280 mEq of K per kg/diet.
The final composition of these diets is shown in Table 1.
The effect of moderate K depletion in non-clipped rats
Ten rats on standard rat chow were compared to eight rats on
the moderately K-depleted diet. Systemic hemodynamics were
determined after 6 weeks.
Natural history of renovascular hypertension in K-replete rats
Five rats on standard rat chow were compared to 13 rats on
the K-depleted diet, which had been supplemented with 240
mEq of K. Systolic blood pressure and weight gain were
determined after 3 and 6 weeks, while plasma and muscle K as
well as systemic hemodynamics were determined after 6 weeks.
In a separate group of seven rats on the K-depleted + K diet,
systemic hemodynamics as well as plasma and muscle K were
determined 3 weeks after clipping.
Since the natural history of hypertension was the same in
both groups of K-replete rats (see below), standard rat chow
was utilized as the K-replete diet for the remainder of the
studies.
The effect of moderate and severe K depletion on the
development of renovascular hypertension
Forty-one rats on the K-replete diet were compared to 42 rats
on the severely K-depleted diet and to 43 rats on the moderately
K-depleted diet. In five to 16 rats in each group, mean arterial
pressure, weight gain, plasma and muscle K content, and
plasma renin activity were determined after 3 and 6 weeks of
the respective diets. Systemic hemodynamics, plasma catechol-
amines, plasma volume, angiotensin II vascular responsivity,
and angiotensin II inhibition studies were determined after 3 to
4 weeks. In addition, plasma renin activity was determined in
normotensive control rats after three (N = 8) and six (N = 8)
weeks of the K-replete diet.
The effects of mild and severe K depletion on established
renovascular hypertension
Following application of the renal artery clip, rats were
maintained on the K-replete diet for 3 wks. Systolic blood
pressure was determined and only rats with systolic blood
pressure over 150 mm Hg were utilized for further study. Seven
rats were maintained on the K-replete diet, seven rats were
placed on the moderately K-depleted diet, and eight rats were
placed on the severely K-depleted diet. Systolic blood pressure
and weight were monitored for 3 additional wks, at which time
the animals were sacrificed for muscle K content determina-
tions.
Systolic blood pressure
Systolic blood pressure was measured by the tail-cuff
plethysmography method (Narco Bio Systems, Houston,
Texas, USA).
Systemic hemodynamics
For hemodynamic studies, animals were anesthetized with
ether and polyethylene catheters were placed in the femoral
artery for direct arterial pressure monitoring (Bell & Howell
Transducer 4-3271, Pasadena, California, USA) and via the
right carotid artery into the left ventricle for injection of
radiolabeled microspheres to determine cardiac output. Correct
placement of the left ventricular catheter was confirmed by the
pressure wave configuration at the time of placement and by
direct visualization at the conclusion of the study. Animals
were allowed to awaken and recover for 60 mm prior to the
injection of plastic microspheres (3M, St. Paul, Minnesota,
USA) 8.8 0.6 in diameter labeled with 85Sr. Cardiac output
was determined by the reference sample method as adapted for
use in our laboratory [11].
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Table 2. The natural history of renovascular hypertension in K-replete rats: animals on standard rat chow are compared to animals on the K-
depleted diet to which K salts had been added
EP Hemodynamics Plasma K
3 wks 6 wks
Muscle K
3 wks 6 wks3 wks
SBP MAP
6 wks
SBP MAP
6 wks
CO SVR
mm Hg mm Hg mm Hg mm Hg ml min' kg' units mEqiliter mEq/kg
K-depleted diet plus 155 149 174 162 269 .680 3.99 3.75 454 460
mixture of K salts 5.2 3.3 6.7 6.1 15.8 .06 .11 .07 11.5 12.4
N (13) (9) (13) (9) (9) (9) (7) (7) (7) (7)
Standard chow 152 166 155 276 .564 3.91 458
(N = 5) 3.4 5.3 7.8 4.5 .03 .14 13.7
P NS NS NS NS NS NS NS
Abbreviations are: SBP, systolic blood pressure; MAP, mean arterial pressure; CO. cardiac output; SVR, systemic vascular resistance.
Numbers in parentheses represent number of animals for that determination.
Plasma volume
Plasma volume was determined by the '251-albumin distribu-
tion space technique that was described by Flamenbaum [171
and has been adapted for use in our laboratory [18].
Plasma and muscle collections
Animals were anesthetized lightly with ether and the left
femoral artery and vein were cannulated with polyethylene
tubing. Animals were then placed in restraining cages and
allowed to recover for 1 hr during which time 1 ml of 0.9%
saline was given. After recovery, arterial pressure and heart
rate was recorded and blood was withdrawn rapidly from the
femoral artery and placed in chilled tubes for determination of
plasma potassium, renin activity, and catecholamines. The
blood was immediately centrifuged at 4°C, the plasma was
decanted and stored at —20°C until it was analyzed. After
sacrificing, a I g sample of psoas muscle was taken for deter-
mination of muscle potassium content.
Plasma K was measured with an 1L343 Flame Photometer
(Instrumentation Laboratories, Inc., Lexington, Massachu-
setts, USA).
Muscle K was determined after nitric acid digestion by
methods described in our laboratory [19].
PRA was determined by RIA [20].
Plasma catecholamines were measured by radioenzymatic
assay using the method of Peuler and Johnson [21].
Response to angiotensin II and angiotensin II blockade
Animals were prepared as for plasma and muscle collections.
After one hr of recovery 100 ng angiotensin II (Sigma Chemical
Co., St. Louis, Missouri, USA) in 0.2 ml of 0.9% saline was
injected. Each drug bolus was followed by injection of 0.2 ml of
0.9% saline to flush the venous catheter. Mean arterial pressure
was recorded continuously. In preliminary studies, we had
determined that this volume of saline resulted in an increment
of mean arterial pressure less than 2 mm Hg. Saralasin (1 Sar 8
Ala—angiotensin II, Norwich-Eaton Pharmaceuticals, Norwich,
New York, USA) was infused at 4 gImin in a total volume of
0.5 ml of 5% dextrose [22] for 30 mm. Mean arterial pressure
was recorded continuously. After the saralasin infusion, anglo-
tensin II was administered as a 100 ng bolus to confirm
angiotensin II receptor blockade.
Weeks
Fig. 1. Weight gain in rats with 2-K, 1-C renovascular hypertension on
the K-replete (0) (N = 16) or the moderately (0) (N = 12) or severely(•) K-depleted (N = 9) diet.
In addition, full pressor dose-response studies utilizing meth-
ods described previously [231 were performed by administering
an intraveneous bolus of angiotensin II in doses of 12.5, 25, 50,
100 ng to seven moderately K-depleted and eight K-replete rats
with renal artery clips.
Statistical analysis was performed using the Student's t test
for single comparisons and one-way analysis of variance for
multiple comparisons. A P value of < 0.05 was considered
significant. Data are expressed as the mean SEM.
Results
The effect of K depletion in non-clipped rats
In earlier studies, we found that there were marked changes
in systemic hemodynamics in severely K-depleted non-clipped
animals: mean arterial pressure was reduced by 10%, systemic
vascular resistance by 27%. Cardiac index was increased by
21% [11]. In contrast to the profound vasodilatory effect of the
severely K-depleted diet, the administration of the moderately
K-depleted diet had a minimal effect on systemic hemodynam-
ics in non-clipped animals: KR (N = 10) vs. KDM (N = 8).
MAP 110 2 compared to 108 3 mm Hg, P = NS; CI 305
22 compared to 330 16 mI/mm kg, P = NS; SVR 0.36
0.04 compared to 0.33 0.03mm Hg/ml min' .kg, P = NS.
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Table 3. The effect of K depletion on plasma and muscle K
3wks 6wks
K-replete
K-depleted,
moderate
K-depleted,
severe K-replete
K-depleted,
moderate
K-depleted,
severe
N
Plasma K, mEqlliter
Muscle K, ,nEq/kg
(13)
4.1 .1
465.9 5.8
(13)
3.5 •1b
428.3a 94
(6)
2.3 •2b
3902b 4.2
(5)
3.8 .1
472.4 10.1
(6)
3.6 Ic
4347a 3•9
(6)
1.8 •1b
295.6b 3.3
a P < 0.01 compared to KR.
"P < 0.001 compared to KR.
P = NS.
Numbers in parentheses represent number of animals for that determination.
Induction of reno vascular hypertension in K-replete animals
Table 2 demonstrates the natural history of 2-K, I-C reno-
vascular hypertension in rats on standard rat chow or on the
K-depleted diet to which 240 mEq of mixture of K salts had
been added. There were no differences in arterial pressure,
systemic hemodynamics, plasma or muscle K between the two
groups. By 3 wks, systolic blood pressure had risen to over 150
mm Hg and increased by approximately 170 mm Hg by 6 wks.
The increase in blood pressure was caused by an increase in
systemic vascular resistance of approximately 41% (lab normal
0.36 to 0.40 mm Hg/mI - min kg). Animals in both groups
gained weight (standard rat chow: 108 10.5 g; K-depleted diet
to which K was added: 110 9.2 g, P = NS) and appeared
healthy despite the marked increase in blood pressure.
The effects of dietary manipulation on growth and plasma
and muscle K
Weight gain in rats with 2-K, 1-C renovascular hypertension
on the K-replete diet (N = 16), the moderately K-depleted diet
(N = 12), and the severely K-depleted diet (N = 9) is shown in
Figure 1. Animals on the severely K-depleted diet did not grow
during the 6-wk study period. At 3 wks, animals fed the
moderately K-depleted diet gained 60% of the weight of animals
fed the K-replete diet (45.3 3.2 g vs. 82 5.6 g, P < 0.001).
By 6 wks, however, cumulative weight gain was comparable
between the two groups (101.0 9.3 in KDM vs. 110.5 9.2 g
KR, P = NS).
Plasma and muscle K values in rats on the three diets are
listed in Table 3. In the severely K-depleted group, plasma K
was reduced to 2.3 0.2 mEqfliter by 3 wks and to 1.9 0.1
mEq/liter at 6 wks (both P < 0.001 vs. K-replete). This was
associated with a 16% decrease in muscle K at 3 wks and a 37%
decrease in muscle K at 6 wks. In the moderately K-depleted
group, plasma K was reduced to 3.5 .1 mEq/liter (P < 0.01
vs. K-replete) at 3 wks and to 3.6 .1 mEq/liter (P = NS vs. K-
replete) at 6 wks. This was associated with an 8% reduction in
muscle K at both 3 and 6 wks. Thus, the administration of the
severely K-depleted diet resulted in severe K depletion and
growth retardation. In contrast, the administration of the mod-
erately K-depleted diet resulted in more moderate K depletion,
which initially stunted growth, but by 6wks did not alter growth
or plasma K despite an 8% decrease in muscle K.
140 P< 0.001
__---'P = NS
ot
Weeks
Fig. 2. Mean arterial pressure in 2-K, I-C renovascular hypertension
with moderate (0) and severe (•) K depletion.
The effect of K depletion on the development of renovascular
hypertension
The effect of K depletion on the development of hypertension
is shown in Figure 2. In K-replete rats mean arterial pressure
reached 154 3 mm Hg at 3 wks (N 24) and 160 8 mm Hg
at 6 wks (N 11). Hypertension was less severe in rats fed
either of the K-depleted diets. In the severely K-depleted
group, mean arterial pressure reached 106 4 mm Hg at 3 wks
(P < 0.001) (N = 20) and 129 5 mm Hg at 6 wks (P < 0.01)
(N = 10). In the moderately K-depleted group, mean arterial
pressure reached 121 2 mm Hg at 3 wks (P < 0.01) (N = 20)
and 132 5 mm Hg at 6 weeks (P < 0.01) (N = 13).
Figure 3 demonstrates the hemodynamic mechanism of the
protective effect of K depletion. The increase in mean arterial
pressure in K-replete rats resulted from an increase in systemic
vascular resistance of 75% as compared to normotensive rats in
our laboratory. In contrast, the administration of both K-
depleted diets prevented the increase in systemic vascular
resistance observed in K-replete rats. Systemic vascular resist-
ance was comparably reduced in both K-depleted groups: KDS
= 0.278 0.01, and KDM = 0.287 .02 mm Hg/mi . min'
kg, P < 0.001 compared to KR. Although increased in both
groups of K-depleted rats, cardiac index was greater in moder-
ately K-depleted animals: (430 29 [KDM] and 349 19 [KDSJ
mI/mm . kg, P < 0.001 KDM compared to KDS). Heart rate
was 442 12 in KDS; 425 10 in KDM; and 435 8 beats per
mm in KR (P = NS compared to both K-depleted groups).
Therefore, the increase in cardiac index in both groups of K-
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depleted animals was caused by an increase in stroke volume.
Since systemic vascular resistance was comparable in both
groups of K-depleted rats, the difference in mean arterial
pressure between severe and moderate K depletion was due to
the difference in cardiac index.
Since the early phase of 2-K, 1-C renovascular hypertension
is associated with an increase in plasma renin activity [221 and
with an increase in activity of the renin-angiotensin system, we
determined whether the protective effect of K depletion in
renovascular hypertension could have resulted from alterations
in the renin-angiotensin system. In K-replete rats, at 3 wks
plasma renin activity was increased to 3 times that of
normotensive rats on the same diet (7.0 1.2 vs. 2.2 .2 ng
AI/mL/hr, P < 0.001). By 6 wks, however, plasma renin activity
in hypertensive rats was the same as that of normotensive rats.
In contrast to K-replete animals, plasma renin activity was
increased at both 3 wks (KDM 6.7 .2 ng AI/mllhr, P = NS vs.
KR, KDS 8.8 .3 ng AI/nL/hr, P < 0.01 vs. KR) and 6 wks
(KDM 5.9 .6, KDS 16.5 1.3 ng AI/mllhr, both P < 0.001 vs.
KR) of K depletion. Thus, the decrease in blood pressure and
systemic vascular resistance in K depletion could not be
attributed to a decrease in plasma renin activity.
The activity of the renin-angiotensin system was further
assessed by determining the pressor response to exogenous
angiotensin II and the depressor response to angiotensin II
receptor binding inhibition in K-replete and moderately K-
depleted rats. There were alterations in activity of the renin-
angiotensin axis in moderate K depletion. The pressor response
to graded doses of angiotensin II in moderately K-deficient rats
was between 32 and 79% of the pressor response of K-replete
rats (Table 4). In addition, the depressor response to the
angiotensin II antagonist was reduced by 80% (KDM —4.2
4.2, N = 6 vs. KR —24.2 8.5 mm Hg, N = 6, P < 0.05).
To determine whether the protective effect of K depletion
was mediated by alterations in volume, plasma volume was
determined in hypertensive animals. Plasma volume was com-
parable in moderately K-depleted (34.4 1.2 mI/kg, N = 7) and
K-replete rats (34.6 4 mI/kg, N = 7, P = NS).
To determine whether the vasodilation of K depletion was
associated with a decrease in the level of circulating catechol-
amines, plasma norepinephrine and epinephrine were measured
in K-replete and K-depleted rats 3 wks after clipping. Plasma
levels of norepinephnne (NE) and epinephrine (E) were similar
Table 4. Pressor dose.response curves to angiotensin II in K-replete
and moderately K-depleted rats with renovascular hypertension
Dose of angiotensin 11
ng
12.5 25 50 100
K-replete (6)
K-depleted,
moderate (8)
P
10.2 2.1
3.6 1.8
0.05
22.1 2.0 31 2.5
7.1 2.8 18 4.6
0.005 0.05
38
30.1 2.1
0.025
Responses in mm Hg above baseline.
Numbers in parentheses are number of animals.
in K-replete and moderately K-depleted rats. In K- replete rats
(N = 6), NE = 613 107 pg/mI and E = 706 108 pg/mI (N =
6) and in moderately K-depleted rats (N = 6), NE = 576 130
pg/mI and E = 506 pg/mI (N = 6) (P = NS for both NE and E).
The effect of K depletion on established renovascular
hypertension
The effect of K depletion on established 2-K, 1-C
renovascular hypertension is shown in Figure 4. Three weeks
after the application of the renal artery clip, systolic blood
pressure was 155 3 mm Hg. After the initiation of either K-
depleted diet, systolic blood pressure fell. By 3 wks, systolic
blood pressure was 120 5 mm Hg in severely K-depleted rats
(N = 6) and 119 4 mm Hg in moderately K-depleted rats (N
= 8) as compared to 161 6 mm Hg (N = 10) in K-replete rats(P = 0.001 compared to both K-depleted groups). Although
animals in the KDS diet did not grow normally, weight gain was
comparable in animals on the KDM (53.2 6.3 g13 wks) and KR
diet (47.0 4.6 g/3 wks), P = NS. Muscle K content in the
moderately K-depleted group was decreased by 8% (439.0 5.6
mEq/kg dry wt) (N = 4).
Discussion
The hemodynamic effects of K have long been debated. In
1928, Addison first noted that K resulted in a decrease in blood
pressure [2]. Since then, there have been many epidemiologic
studies that have demonstrated an inverse relationship between
the K content of the diet and blood pressure [24—27]. In
C
E
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0
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rather than K depletion per Se, we performed further studies in
rats with more moderate K depletion by utilizing a diet that
resulted in a reduction in muscle K of 8% after both 3 and 6
wks. Although rats on the moderate K-depleted diet did not
grow initially at the same rate as rats on a K-replete diet, the
rate of weight gain was actually greater in moderately K-
depleted rats between 3 and 6 wks so that after 6 wks,
moderately K-depleted and K-replete rats had grown compara-
bly (Fig. 1). After both 3 and 6 wks, mean arterial pressure was
less in moderately K-depleted rats (Fig. 2). Since the
hypotensive effect occurred in the absence of growth retarda-
KR diet KR diet tion, the protective effect of moderate K depletion was not
KD diet caused by growth retardation but by K depletion.
_______________________________________________ We tested a number of possible explanations for the decrease
Clip 1 2 3 4 5 6 in systemic vascular resistance in K-depleted rats. These in-
Weeks cluded studies of plasma volume, plasma catecholamines, and
the renin-angiotensin system. Although K depletion results in a
decrease in aldosterone [36] and a decrease in aldosterone could
result in a decrease in plasma volume and blood pressure,
plasma volume was comparable in moderately K-depleted and
K-replete rats. Taken together with earlier studies in which we
found plasma volume to be increased in normotensive severely
addition, there have been a number of experimental studies that K-depleted rats [11], it seems unlikely that changes in plasma
have demonstrated that K administration reduces blood pres- volume account for the decrease in systemic vascular resistance
sure in rats with Na-sensitive hypertension [28], renovascular in K depletion. Moreover, while others have reported that K
hypertension [29], or spontaneous hypertension [301, as well as depletion interferes with catecholamine release [37], we found
in patients with mild essential hypertension [5, 6]. Although the that plasma norepinephrine and epinephrine were comparable
protective effect of K supplementation apppears to be related to in replete and moderately K-depleted animals. Thus, a decrease
the well-known natnuresis and decrease in plasma volume that in plasma catecholamines could not account for the protective
results from K supplementation [29, 311, there are additional effect of moderate K depletion.
mechanisms by which K reduces blood pressure since the Since an increase in angiotensin II mediates the increase in
protective effect of K has been described in the absence of mean arterial pressure and systemic vascular resistance in the
sodium loss [30]. early phase of 2-K, I-C renovascular hypertension [22, 38], we
The hemodynamic effects of K depletion are less clear. While determined whether changes in plasma renin activity or changes
acute hypokalemia as occurs when vessels or limbs from in the vascular sensitivity to angiotensin II could be an expla-
normotensive animals are perfused with hypokalemic solutions nation for the protective effect of K depletion. In K-replete rats
results in vasoconstriction [32—34], severe total body K deple- there was an initial increment in plasma renin activity which, as
tion in normotensive animals results in vasodilatation [11—13]. has been described previously, was not noted after 6 wks of
Moreover, in experimental models of renal hypertension [8, 9] hypertension [22]. In both groups of K-depleted rats, however,
and in patients with essential hypertension [35], severe K plasma renin activity was increased after both 3 and 6 wks of
depletion results in a decrease in blood pressure. However, hypertension. Thus, the protective effect of K depletion could
severe K depletion also causes growth retardation and the not be attributed to a decrease in renin release.
protective effect of K depletion has not been dissociated from In contrast to the lack of effect on renin release, there was a
growth retardation. decrease in vascular sensitivity to angiotensin II in moderately
In the present study, we have determined the effect of K-depleted animals. In this regard, despite increased levels of
moderate and severe K depletion on the natural history of 2-K, plasma renin activity, systemic vascular resistance was de-
l-c renovascular hypertension. The results indicate clearly that creased (Fig. 3), the hypotensive response following angioten-
K depletion not only prevented the development of hyperten- sin II antagonism was reduced by 80%, and the pressor re-
sion (Fig. 2) but also reversed established hypertension (Fig. 4). sponse to exogenous angiotensin II was reduced by 32 to 79%
The primary mechanism by which K depletion ameliorated (Table 4).
renovascular hypertension was by preventing the increase in While the decrease in angiotensin II vascular reactivity could
systemic vascular resistance which characterizes renovascular be caused by either a decrease in angiotensin II binding to its
hypertension (Fig. 3). putative vascular receptor or to post-receptor events, in prior
In our initial study, rats were severely K depleted. We chose studies we found that severe K depletion in normotensive rats
this model of K depletion because it has been utilized by many resulted in an increase in angiotensin II binding [23]. Thus, the
laboratories [7, 9, 12, 13], including our own [11, 19], to study decreased reactivity in moderately K-depleted rats with RVH is
the effects of K depletion on renal function. Although rats with likely mediated by a post-receptor defect. Since the specific
severe K depletion were protected from hypertension, they did post-receptor events which are mediated by angiotensin II are
not grow normally (Fig. 1). To determine whether the protec- not known, we can only speculate as to the manner by which K
tive effect of K depletion was caused by growth retardation depletion alters these events. The post-receptor response to
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Fig. 4. Systolic blood pressure in rats with established 2-K, 1-C
renovascular hypertension continued on the K-replete (0) (N = 10) diet
or in rats switched to the moderately (0) (N = 8) or severely (•) (N =
6) K-depleted diet.
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angiotensin II may be dependent upon phosphorylation of
contractile proteins [39], alterations in membrane phospholipids
[40, 411, and changes in intracellular calcium [42]. K depletion
could alter the effect of angiotensin II at these or other sites.
While there are no studies on the effect of chronic K depletion
on contractile proteins, Toback et al, using renal tissue, have
shown that K depletion alters membrane phospholipid metab-
olism [43]. Recent evidence suggests that ion transport across
plasma membranes may be determined by the phospholipid
composition of the membrane [44]. Since the vasoconstrictor
effect of angiotensin II may be mediated by calcium transport
across the plasma membrane [42], it seems reasonable to
hypothesize that the post-receptor defect of K depletion may be
mediated in part by alterations in membrane phospholipid
metabolism induced by K depletion.
In summary, we have shown that moderate (8% decrease in
muscle K) as well as severe (16 to 37% decrease in muscle K) K
depletion prevented the development of hypertension and re-
versed established hypertension in 2-K, 1-C renovascular hy-
pertension. While severely K-depleted rats did not grow,
weight gain in moderately K-depleted and K-replete rats was
comparable after 6 wks. The protective effect of K depletion
was not mediated by a decrease in plasma volume or in plasma
catecholamines. In contrast, the decrease in systemic vascular
resistance was associated with an increase in plasma renin
activity and with a decrease in pressor sensitivity to angiotensin
II. We conclude that moderate K depletion has a hypotensive
effect in 2-K, 1-C renovascular hypertension that is most
likely mediated by a decrease in effectiveness of circulating
angiotensin II.
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